valsartan has been researched along with Tachycardia, Ventricular in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abumayyaleh, M; Akin, I; Aweimer, A; Crack, C; Demmer, J; El-Battrawy, I; Mügge, A; Pilsinger, C; Zhou, X | 1 |
| Acquaro, M; Ghio, S; Greco, A; Pasotti, B; Rordorf, R; Sanzo, A; Savastano, S; Scelsi, L; Schirinzi, S; Seganti, A; Spolverini, M; Turco, A | 1 |
| Chang, PC; Chou, CC; Chu, Y; Lee, HL; Lin, SF; Wen, MS; Wo, HT | 1 |
| Alcalde, RO; Alonso-Martín, C; Arbòs, CM; Bruña, V; Devesa, C; Fernández-Avilés, F; Juárez, M; Martínez-Sellés, M; Méndez-Zurita, F; Pamies, J; Sousa-Casasnovas, I; Vicent, L; Viñolas, X | 1 |
| Bellocci, F; Crea, F; Giubilato, G; Ierardi, C; Pieroni, M; Santangeli, P; Vitulano, N | 1 |
| Doi, M; Kobayashi, S; Kohno, M; Matsuzaki, M; Oda, T; Ohkusa, T; Okuda, S; Tokuhisa, T; Yamamoto, T; Yano, M | 1 |
6 other study(ies) available for valsartan and Tachycardia, Ventricular
| Article | Year |
|---|---|
The impact of sacubitril/valsartan on outcome in patients suffering from heart failure with a concomitant diabetes mellitus.
Topics: Aged; Atrial Fibrillation; Diabetes Mellitus; Heart Failure; Humans; Stroke Volume; Tachycardia, Ventricular; Tetrazoles; Troponin I; Valsartan; Ventricular Function, Left | 2023 |
Sacubitril/valsartan effects on arrhythmias and left ventricular remodelling in heart failure: An observational study.
Topics: Angiotensin Receptor Antagonists; Arrhythmias, Cardiac; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Stroke Volume; Tachycardia, Ventricular; Tetrazoles; Treatment Outcome; Valsartan; Ventricular Function, Left; Ventricular Remodeling | 2023 |
Sacubitril/Valsartan Therapy Ameliorates Ventricular Tachyarrhythmia Inducibility in a Rabbit Myocardial Infarction Model.
Topics: Aminobutyrates; Animals; Biphenyl Compounds; Drug Combinations; Heart Failure; Myocardial Infarction; Rabbits; Stroke Volume; Tachycardia, Ventricular; Valsartan; Ventricular Function, Left | 2020 |
Clinical characteristics of patients with sustained ventricular arrhythmias after sacubitril/valsartan initiation.
Topics: Aged; Aged, 80 and over; Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Drug Combinations; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Neprilysin; Protease Inhibitors; Risk Assessment; Risk Factors; Spain; Tachycardia, Ventricular; Tetrazoles; Time Factors; Treatment Outcome; Valsartan | 2020 |
Continuous positive airway pressure treatment in addition to optimal medical therapy for ventricular ectopy in a patient with heart failure and sleep-related breathing disorder.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Continuous Positive Airway Pressure; Coronary Artery Disease; Heart Failure; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Propanolamines; Radiography; Sleep Apnea, Obstructive; Tachycardia, Ventricular; Tetrazoles; Ultrasonography; Valine; Valsartan; Ventricular Premature Complexes | 2013 |
Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Signaling; Calcium-Transporting ATPases; Cardiac Pacing, Artificial; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dobutamine; Dogs; Drug Evaluation, Preclinical; Heart Failure; Myocardial Contraction; Norepinephrine; Phosphorylation; Protein Processing, Post-Translational; Receptors, Adrenergic, beta; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Tachycardia, Ventricular; Tacrolimus Binding Proteins; Tetrazoles; Valine; Valsartan; Ventricular Remodeling | 2004 |